シングルセル解析市場の市場規模、シェア、動向分析レポート：製品別、用途別、ワークフロー別、最終用途別、地域別、セグメント予測、2024年～2030年

シングルセル解析市場の成長と動向：

世界のシングルセル解析市場規模は2030年に136億9,000万米ドルと推計され、2024年から2030年にかけてCAGR 18.7%で成長すると予測されています。

技術の進歩、がん研究における用途の拡大、細胞ベースの研究に対する政府助成金の増加が市場の主な促進要因です。さらに、COVID-19パンデミックの結果、市場は進展しています。例えば、2021年1月、American Journal of Physiologyによると、COVID-19感染患者の末梢血単核細胞プロファイルの変動が、マスサイトメトリーによるシングルセル解析（SEA）を用いて調べられ、これが業界の成長を補足しました。

現在進行中のパンデミックの経済的・社会的コストに対応するため、世界中の政府機関がワクチン開発・製造のための資金を増額しており、COVID-19研究のためのSEAツールの使用が増加しています。より良い予後・診断指標を開発し、重篤な病態を呈する人々に対する適切な治療アプローチを確立するためには、病原性を通して宿主の免疫反応を知ることが不可欠です。したがって、COVID-19は、シングルセル分析が疾患における末梢免疫機能の評価に役立ち、疾患の病態生理学と治療の可能性の研究に新たな貢献をするため、市場にプラスの影響を与えます。

シングルセル技術は、経路やプロセスの分子レベルの検査、細胞の不均一性の評価に役立ちます。この技術は、腫瘍学、免疫学、その他の分野で急速に発展しています。さらに、トランスクリプトームやプロテオーム過程をより単純化する洗練されたツールの開発が、SEA法の使用を後押ししています。研究者は現在、scRNAシーケンス（scRNAseq）の発展により、以前は研究されていなかった一般的でない細胞タイプを包括的に調べることができるようになった。バイオメディカル分野でのシングルセルゲノム／トランスクリプトーム解析の応用は、マイクロ流体技術の発展によって大きく広がった。さらに、細胞の解離や組織の消化は、様々なマイクロ流体デバイスに適応され、SEA技術の採用を増加させ、業界の成長をさらに後押ししています。

この分野における研究開発への投資フローの増加は、研究発表数の増加にも反映されています。例えば、2020年4月には、ベンチャーキャピタルのi&i Biotech Fundが、遺伝子組み換え細胞を使って環境中の他の細胞を検査する診断プラットフォームを開発した若い生命科学技術の新興企業Sampling Humanに200万米ドルの資金を提供しました（i&i Bio）。さらに、研究開発と事業の成長はすべて、この投資によって促進されます。さらに、研究開発努力は技術革新の基礎となるため、こうした支出はこの市場のより良い成長機会を示しています。さらに、科学者たちは遺伝子発現プロファイルの地域変動をシングルセルレベルで分析しており、これは分析用の消耗品や機器の需要を増加させ、業界の成長を促進すると予想されます。

シングルセル解析市場レポートハイライト

• 製品別では、消耗品セグメントが2021年に最大の収益シェアを占めました。このセグメントは、遺伝子研究、エクソソーム分析、RNAおよびDNA単離における消耗品の広範な使用によって牽引されると予測されます。
• 用途別では、がん分野が2022年に最大の収益シェアを獲得しました。同分野を牽引しているのは、がんの早期診断に有効であることが示されているシングルセル解析です。これらの技術により、細胞の種類、変異率、成長設定を簡単に決定することができます。
• ワークフローでは、単一細胞分離とライブラリー調製セグメントが2022年に最大の収益シェアを占めました。シングルセル解析を用いた研究の増加が収益成長を押し上げると予測されています。
• 最終用途別では、学術・研究機関セグメントが2022年に最大の収益シェアを占めました。研究環境におけるさまざまなSEA技術の広範な使用は、SEAアッセイを使用する学術機関で進行中の研究プロジェクトの数に影響されています。
• 北米は2022年に最大の収益シェアを占めました。これは、市場参入企業が多いこと、R&D支出や連邦政府の援助が増加していることが主な要因です。
• アジア太平洋地域は、対象疾患の有病率の増加、高齢化人口の増加、単一細胞技術の採用増加などの要因により、予測期間中に最も高い成長率を示すと予想されます。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 シングルセル解析市場の変数、動向、範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/補助的な市場見通し。
• 市場力学
  • 市場牽引要因分析
  • 市場抑制要因分析
• シングルセル解析市場分析ツール
  • 業界分析- ポーターのファイブフォース分析
  • PESTEL分析
  • COVID-19の影響分析

第4章 シングルセル解析市場：製品推定・動向分析

• セグメントダッシュボード
• 世界のシングルセル解析市場の製品変動分析
• 世界のシングルセル解析市場規模と動向分析、製品別、2018～2030年
• 消耗品
• 機器

第5章 シングルセル解析市場：用途の推定・動向分析

• セグメントダッシュボード
• 世界のシングルセル解析市場の用途変動分析
• 世界のシングルセル解析市場規模と動向分析、用途別、2018～2030年
• がん
• 免疫学
• 神経学
• 幹細胞
• 非侵襲的出生前診断
• 体外受精
• 心臓細胞
• 骨格細胞と筋細胞
• その他

第6章 シングルセル解析市場：ワークフローの推定・動向分析

• セグメントダッシュボード
• 世界シングルセル解析市場のワークフロー変動分析
• 2018年から2030年までのワークフロー別世界シングルセル解析市場規模と動向分析
• 単一細胞分離とライブラリー調製
• ダウンストリーム分析
• データ分析

第7章 シングルセル解析市場：最終用途の推定・動向分析

• セグメントダッシュボード
• 世界のシングルセル解析市場の最終用途変動分析
• 世界のシングルセル解析市場規模と動向分析、最終用途別、2018～2030年
• 学術研究室
• バイオテクノロジーおよび製薬企業
• 病院および診断検査室
• その他

第8章 シングルセル解析市場： 製品、用途、ワークフロー、最終用途別の地域推定・動向分析。

• 地域市場ダッシュボード
• 地域別市場シェア分析、2024年および2030年
• 市場規模、予測動向分析、2018年から2030年：
• 北米
• 欧州
• アジア太平洋地域
• ラテンアメリカ
• 中東・アフリカ

第9章 競合情勢

• 財務実績
• 参入企業
• 企業市況分析、2024年
• 企業プロファイル/上場企業
  • Thermo Fisher Scientific, Inc
  • QIAGEN NV
  • Bio-Rad Laboratories, Inc.
  • Illumina, Inc.
  • Merck KGaA
  • Becton, Dickinson &Company（BD）
  • Fluidigm Corporation（Standard BioTools Inc.）
  • 10x Genomics, Inc.
  • BGI
  • Novogene Co, Ltd.

List of Tables

• Table 1 Clinical trial analysis
• Table 2 List of secondary sources
• Table 3 List of abbreviations
• Table 4 Global single-cell analysis market, by region, 2018 - 2030 (USD Million)
• Table 5 Global single-cell analysis market, by product, 2018 - 2030 (USD Million)
• Table 6 NGS instruments: comparison
• Table 7 Global single-cell analysis market, by application, 2018 - 2030 (USD Million)
• Table 8 Global single-cell analysis market, by workflow, 2018 - 2030 (USD Million)
• Table 9 Global single-cell analysis market, by end-use, 2018 - 2030 (USD Million)
• Table 10 North America single-cell analysis market, by country, 2018 - 2030 (USD Million)
• Table 11 North America single-cell analysis market, by product, 2018 - 2030 (USD Million)
• Table 12 North America single-cell analysis market, by application, 2018 - 2030 (USD Million)
• Table 13 North America single-cell analysis market, by workflow, 2018 - 2030 (USD Million)
• Table 14 North America single-cell analysis market, by end-use, 2018 - 2030 (USD Million)
• Table 15 U.S. single-cell analysis market, by product, 2018 - 2030 (USD Million)
• Table 16 U.S. single-cell analysis market, by application, 2018 - 2030 (USD Million)
• Table 17 U.S. single-cell analysis market, by workflow, 2018 - 2030 (USD Million)
• Table 18 U.S. single-cell analysis market, by end-use, 2018 - 2030 (USD Million)
• Table 19 Canada single-cell analysis market, by product, 2018 - 2030 (USD Million)
• Table 20 Canada single-cell analysis market, by application, 2018 - 2030 (USD Million)
• Table 21 Canada single-cell analysis market, by workflow, 2018 - 2030 (USD Million)
• Table 22 Canada single-cell analysis market, by end-use, 2018 - 2030 (USD Million)
• Table 23 Europe single-cell analysis market, by country, 2018 - 2030 (USD Million)
• Table 24 Europe single-cell analysis market, by product, 2018 - 2030 (USD Million)
• Table 25 Europe single-cell analysis market, by application, 2018 - 2030 (USD Million)
• Table 26 Europe single-cell analysis market, by workflow, 2018 - 2030 (USD Million)
• Table 27 Europe single-cell analysis market, by end-use, 2018 - 2030 (USD Million)
• Table 28 Germany single-cell analysis market, by product, 2018 - 2030 (USD Million)
• Table 29 Germany single-cell analysis market, by application, 2018 - 2030 (USD Million)
• Table 30 Germany single-cell analysis market, by workflow, 2018 - 2030 (USD Million)
• Table 31 Germany single-cell analysis market, by end-use, 2018 - 2030 (USD Million)
• Table 32 UK single-cell analysis market, by product, 2018 - 2030 (USD Million)
• Table 33 UK single-cell analysis market, by application, 2018 - 2030 (USD Million)
• Table 34 UK single-cell analysis market, by workflow, 2018 - 2030 (USD Million)
• Table 35 UK single-cell analysis market, by end-use, 2018 - 2030 (USD Million)
• Table 36 France single-cell analysis market, by product, 2018 - 2030 (USD Million)
• Table 37 France single-cell analysis market, by application, 2018 - 2030 (USD Million)
• Table 38 France single-cell analysis market, by workflow, 2018 - 2030 (USD Million)
• Table 39 France single-cell analysis market, by end-use, 2018 - 2030 (USD Million)
• Table 40 Italy single-cell analysis market, by product, 2018 - 2030 (USD Million)
• Table 41 Italy single-cell analysis market, by application, 2018 - 2030 (USD Million)
• Table 42 Italy single-cell analysis market, by workflow, 2018 - 2030 (USD Million)
• Table 43 Italy single-cell analysis market, by end-use, 2018 - 2030 (USD Million)
• Table 44 UK single-cell analysis market, by product, 2018 - 2030 (USD Million)
• Table 45 Spain single-cell analysis market, by application, 2018 - 2030 (USD Million)
• Table 46 Spain single-cell analysis market, by workflow, 2018 - 2030 (USD Million)
• Table 47 Spain single-cell analysis market, by end-use, 2018 - 2030 (USD Million)
• Table 48 Denmark single-cell analysis market, by product, 2018 - 2030 (USD Million)
• Table 49 Denmark single-cell analysis market, by application, 2018 - 2030 (USD Million)
• Table 50 Denmark single-cell analysis market, by workflow, 2018 - 2030 (USD Million)
• Table 51 Denmark single-cell analysis market, by end-use, 2018 - 2030 (USD Million)
• Table 52 Sweden single-cell analysis market, by product, 2018 - 2030 (USD Million)
• Table 53 Sweden single-cell analysis market, by application, 2018 - 2030 (USD Million)
• Table 54 Sweden single-cell analysis market, by workflow, 2018 - 2030 (USD Million)
• Table 55 Sweden single-cell analysis market, by end-use, 2018 - 2030 (USD Million)
• Table 56 Norway single-cell analysis market, by product, 2018 - 2030 (USD Million)
• Table 57 Norway single-cell analysis market, by application, 2018 - 2030 (USD Million)
• Table 58 Norway single-cell analysis market, by workflow, 2018 - 2030 (USD Million)
• Table 59 Norway single-cell analysis market, by end-use, 2018 - 2030 (USD Million)
• Table 60 Asia Pacific single-cell analysis market, by country, 2018 - 2030 (USD Million)
• Table 61 Asia Pacific single-cell analysis market, by product, 2018 - 2030 (USD Million)
• Table 62 Asia Pacific single-cell analysis market, by application, 2018 - 2030 (USD Million)
• Table 63 Asia Pacific single-cell analysis market, by workflow, 2018 - 2030 (USD Million)
• Table 64 Asia Pacific single-cell analysis market, by end-use, 2018 - 2030 (USD Million)
• Table 65 China single-cell analysis market, by product, 2018 - 2030 (USD Million)
• Table 66 China single-cell analysis market, by application, 2018 - 2030 (USD Million)
• Table 67 China single-cell analysis market, by workflow, 2018 - 2030 (USD Million)
• Table 68 China single-cell analysis market, by end-use, 2018 - 2030 (USD Million)
• Table 69 Japan single-cell analysis market, by product, 2018 - 2030 (USD Million)
• Table 70 Japan single-cell analysis market, by application, 2018 - 2030 (USD Million)
• Table 71 Japan single-cell analysis market, by workflow, 2018 - 2030 (USD Million)
• Table 72 Japan single-cell analysis market, by end-use, 2018 - 2030 (USD Million)
• Table 73 India single-cell analysis market, by product, 2018 - 2030 (USD Million)
• Table 74 India single-cell analysis market, by application, 2018 - 2030 (USD Million)
• Table 75 India single-cell analysis market, by workflow, 2018 - 2030 (USD Million)
• Table 76 India single-cell analysis market, by end-use, 2018 - 2030 (USD Million)
• Table 77 South Korea single-cell analysis market, by product, 2018 - 2030 (USD Million)
• Table 78 South Korea single-cell analysis market, by application, 2018 - 2030 (USD Million)
• Table 79 South Korea single-cell analysis market, by workflow, 2018 - 2030 (USD Million)
• Table 80 South Korea single-cell analysis market, by end-use, 2018 - 2030 (USD Million)
• Table 81 Australia single-cell analysis market, by product, 2018 - 2030 (USD Million)
• Table 82 Australia single-cell analysis market, by application, 2018 - 2030 (USD Million)
• Table 83 Australia single-cell analysis market, by workflow, 2018 - 2030 (USD Million)
• Table 84 Australia single-cell analysis market, by end-use, 2018 - 2030 (USD Million)
• Table 85 Thailand single-cell analysis market, by product, 2018 - 2030 (USD Million)
• Table 86 Thailand single-cell analysis market, by application, 2018 - 2030 (USD Million)
• Table 87 Thailand single-cell analysis market, by workflow, 2018 - 2030 (USD Million)
• Table 88 Thailand single-cell analysis market, by end-use, 2018 - 2030 (USD Million)
• Table 89 Latin America single-cell analysis market, by country, 2018 - 2030 (USD Million)
• Table 90 Latin America single-cell analysis market, by product, 2018 - 2030 (USD Million)
• Table 91 Latin America single-cell analysis market, by application, 2018 - 2030 (USD Million)
• Table 92 Latin America single-cell analysis market, by workflow, 2018 - 2030 (USD Million)
• Table 93 Latin America single-cell analysis market, by end-use, 2018 - 2030 (USD Million)
• Table 94 Brazil single-cell analysis market, by product, 2018 - 2030 (USD Million)
• Table 95 Brazil single-cell analysis market, by application, 2018 - 2030 (USD Million)
• Table 96 Brazil single-cell analysis market, by workflow, 2018 - 2030 (USD Million)
• Table 97 Brazil single-cell analysis market, by end-use, 2018 - 2030 (USD Million)
• Table 98 Mexico single-cell analysis market, by product, 2018 - 2030 (USD Million)
• Table 99 Mexico single-cell analysis market, by application, 2018 - 2030 (USD Million)
• Table 100 Mexico single-cell analysis market, by workflow, 2018 - 2030 (USD Million)
• Table 101 Mexico single-cell analysis market, by end-use, 2018 - 2030 (USD Million)
• Table 102 Argentina single-cell analysis market, by product, 2018 - 2030 (USD Million)
• Table 103 Argentina single-cell analysis market, by application, 2018 - 2030 (USD Million)
• Table 104 Argentina single-cell analysis market, by workflow, 2018 - 2030 (USD Million)
• Table 105 Argentina single-cell analysis market, by end-use, 2018 - 2030 (USD Million)
• Table 106 MEA single-cell analysis market, by country, 2018 - 2030 (USD Million)
• Table 107 MEA single-cell analysis market, by product, 2018 - 2030 (USD Million)
• Table 108 MEA single-cell analysis market, by application, 2018 - 2030 (USD Million)
• Table 109 MEA single-cell analysis market, by workflow, 2018 - 2030 (USD Million)
• Table 110 MEA single-cell analysis market, by end-use, 2018 - 2030 (USD Million)
• Table 111 South Africa single-cell analysis market, by product, 2018 - 2030 (USD Million)
• Table 112 South Africa single-cell analysis market, by application, 2018 - 2030 (USD Million)
• Table 113 South Africa single-cell analysis market, by workflow, 2018 - 2030 (USD Million)
• Table 114 South Africa single-cell analysis market, by end-use, 2018 - 2030 (USD Million)
• Table 115 Saudi Arabia single-cell analysis market, by product, 2018 - 2030 (USD Million)
• Table 116 Saudi Arabia single-cell analysis market, by application, 2018 - 2030 (USD Million)
• Table 117 Saudi Arabia single-cell analysis market, by workflow, 2018 - 2030 (USD Million)
• Table 118 Saudi Arabia single-cell analysis market, by end-use, 2018 - 2030 (USD Million)
• Table 119 UAE single-cell analysis market, by product, 2018 - 2030 (USD Million)
• Table 120 UAE single-cell analysis market, by application, 2018 - 2030 (USD Million)
• Table 121 UAE single-cell analysis market, by workflow, 2018 - 2030 (USD Million)
• Table 122 UAE single-cell analysis market, by end-use, 2018 - 2030 (USD Million)
• Table 123 Kuwait single-cell analysis market, by product, 2018 - 2030 (USD Million)
• Table 124 Kuwait single-cell analysis market, by application, 2018 - 2030 (USD Million)
• Table 125 Kuwait single-cell analysis market, by workflow, 2018 - 2030 (USD Million)
• Table 126 Kuwait single-cell analysis market, by end-use, 2018 - 2030 (USD Million)
• Table 127 Key companies undertaking acquisitions
• Table 128 Key companies launching new products/services
• Table 129 Key companies undertaking collaborations and partnerships
• Table 130 Key companies undertaking other initiatives

List of Figures

• Fig. 1 Single-cell analysis market segmentation
• Fig. 2 Market research process
• Fig. 3 Data triangulation techniques
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Value-chain-based sizing & forecasting
• Fig. 7 QFD modelling for market share assessment
• Fig. 8 Market formulation & validation
• Fig. 9 Market snapshot
• Fig. 10 Segment snapshot
• Fig. 11 Competitive landscape snapshot
• Fig. 12 Parent market outlook
• Fig. 13 Related/ancillary market outlook
• Fig. 14 Genomics - Industry value chain analysis
• Fig. 15 Single-cell analysis market driver analysis
• Fig. 16 Single-cell analysis market restraint analysis
• Fig. 17 Single-cell analysis market: Porter's analysis
• Fig. 18 Single-cell analysis market: Product outlook key takeaways
• Fig. 19 Single-cell analysis market: Product movement analysis
• Fig. 20 Consumables market, 2018 - 2030 (USD Million)
• Fig. 21 Reagents market, 2018 - 2030 (USD Million)
• Fig. 22 Assay kits market, 2018 - 2030 (USD Million)
• Fig. 23 Instruments market, 2018 - 2030 (USD Million)
• Fig. 24 Microscopes market, 2018 - 2030 (USD Million)
• Fig. 25 Hemocytometers market, 2018 - 2030 (USD Million)
• Fig. 26 Flow cytometers market, 2018 - 2030 (USD Million)
• Fig. 27 Next-generation sequencing market, 2018 - 2030 (USD Million)
• Fig. 28 PCR systems market, 2018 - 2030 (USD Million)
• Fig. 29 High-content screening system market, 2018 - 2030 (USD Million)
• Fig. 30 Cell microarrays market, 2018 - 2030 (USD Million)
• Fig. 31 Single live cell imaging market, 2018 - 2030 (USD Million)
• Fig. 32 Automated cell counters market, 2018 - 2030 (USD Million)
• Fig. 33 Single-cell analysis market: Application outlook & key takeaways
• Fig. 34 Single-cell analysis market: Application movement analysis
• Fig. 35 Cancer market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 36 Immunology market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 37 Neurology market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 38 Stem cell market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 39 Non-invasive prenatal diagnosis market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 40 In-vitro fertilization market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 41 Others market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 42 Single-cell analysis market: Workflow outlook & key takeaways
• Fig. 43 Single-cell analysis market: Workflow movement analysis
• Fig. 44 Single-cell isolation & library preparation market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 45 Downstream analysis market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 46 Data analysis market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 47 Single-cell analysis market: End-use outlook key takeaways
• Fig. 48 Single-cell analysis market: End-use movement analysis
• Fig. 49 Academic & research laboratories market, 2018 - 2030 (USD Million)
• Fig. 50 Biotechnology & pharmaceutical companies market, 2018 - 2030 (USD Million)
• Fig. 51 Hospital & diagnostic laboratories market, 2018 - 2030 (USD Million)
• Fig. 52 Others market, 2018 - 2030 (USD Million)
• Fig. 53 Single-cell analysis market revenue, by region, 2024 & 2030 (USD Million)
• Fig. 54 Key marketplace: Key takeaways
• Fig. 55 North America single-cell analysis market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 56 Key country dynamics
• Fig. 57 U.S. single-cell analysis market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 58 Key country dynamics
• Fig. 59 Canada single-cell analysis market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 60 Europe single-cell analysis market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 61 Key country dynamics
• Fig. 62 UK single-cell analysis market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 63 Key country dynamics
• Fig. 64 Germany single-cell analysis market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 65 Key country dynamics
• Fig. 66 France single-cell analysis market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 67 Key country dynamics
• Fig. 68 Spain single-cell analysis market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 69 Key country dynamics
• Fig. 70 Italy single-cell analysis market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 71 Key country dynamics
• Fig. 72 Denmark single-cell analysis market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 73 Key country dynamics
• Fig. 74 Sweden single-cell analysis market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 75 Key country dynamics
• Fig. 76 Norway single-cell analysis market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 77 Asia Pacific single-cell analysis market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 78 Key country dynamics
• Fig. 79 Japan single-cell analysis market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 80 Key country dynamics
• Fig. 81 China single-cell analysis market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 82 Key country dynamics
• Fig. 83 India single-cell analysis market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 84 Key country dynamics
• Fig. 85 Australia single-cell analysis market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 86 Key country dynamics
• Fig. 87 South Korea single-cell analysis market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 88 Key country dynamics
• Fig. 89 Thailand single-cell analysis market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 90 Latin America single-cell analysis market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 91 Key country dynamics
• Fig. 92 Brazil single-cell analysis market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 93 Key country dynamics
• Fig. 94 Mexico single-cell analysis market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 95 Key country dynamics
• Fig. 96 Argentina single-cell analysis market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 97 Middle East and Africa single-cell analysis market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 98 Key country dynamics
• Fig. 99 South Africa single-cell analysis market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 100 Key country dynamics
• Fig. 101 Saudi Arabia single-cell analysis market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 102 Key country dynamics
• Fig. 103 UAE single-cell analysis market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 104 Key country dynamics
• Fig. 105 Kuwait single-cell analysis market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 106 Market participant categorization
• Fig. 107 Market position analysis, 2024
• Fig. 108 Strategic framework

Single-cell Analysis Market Growth & Trends:

The global single-cell analysis market size was estimated at USD 13.69 billion in 2030 and is projected to grow at a CAGR of 18.7% from 2024 to 2030. Technology advances, expanding applications in cancer research, and higher government funding for cell-based research are the main drivers of the market. In addition, the market is advancing as a result of the COVID-19 pandemic. For instance, in January 2021, according to the American Journal of Physiology, variations in the peripheral blood mononuclear cellular profiles of COVID-19-infected patients were examined by using single-cell analysis (SEA) through mass cytometry, which supplemented the industry growth.

Government agencies around the world have increased funding for vaccine development and production in response to the ongoing pandemic's economic and social costs, which has increased the use of SEA tools for COVID-19 research. In order to develop better prognostic and diagnostic indicators and establish suitable therapeutic approaches for people with serious disease presentation, it is essential to know the host immune response throughout pathogenicity. Therefore, the market is positively impacted by COVID-19 because single-cell analysis helps in the assessment of peripheral immune function in the disease and makes new contributions to the study of the disease's pathophysiology and treatment possibilities.

Single-cell technology aids in the molecular level examination of pathways and processes as well as the assessment of cellular heterogeneity. This technology is developing rapidly with uses in oncology, immunology, and other fields. Further, the development of sophisticated tools that make transcriptomic and proteomic processes simpler is boosting the use of SEA methods. Researchers are now able to comprehensively examine previously unstudied uncommon cell types owing to developments in scRNA sequencing (scRNAseq). The application of single-cell genomic/transcriptomic analysis in the biomedical area has been greatly expanded by the development of microfluidics technology. Furthermore, cell dissociation and tissue digestion have been adapted for a large range of microfluidic devices, which have increased the adoption of SEA technology and further boosted industry growth.

The rising investment flow in R&D in this space is reflected in the rising number of research publications. For instance, in April 2020, A USD 2 million funding round was headed by the venture capital firm i&i Biotech Fund for Sampling Human, a young life science technology startup that has created a diagnostic platform that uses genetically modified cells to examine other cells in their environment (i&i Bio). Further, R&D and business growth will all be advanced by the investment. Moreover, these expenditures indicate a better growth opportunity for this market because R&D efforts serve as the foundation for innovation. Additionally, scientists are analyzing geographic variability in gene expression profiles at the single-cell level, which is expected to increase the demand for consumables and equipment for analysis, thus propelling the industry's growth.

Single-cell Analysis Market Report Highlights:

• By product, the consumables segment held the largest revenue share in 2021. The segment is anticipated to be driven by the extensive use of consumables in genetic research, exosome analysis, and RNA and DNA isolation
• Based on application, the cancer segment captured the largest revenue share in 2022. The segment is being driven by single-cell analysis, which has shown to be successful for earlier cancer diagnoses. These techniques make it simple to determine cell kinds, mutation rates, and growth settings
• In terms of workflow, the single cell isolation and library preparation segment held the largest revenue share in 2022. Increasing research using single-cell analysis is anticipated to boost the revenue growth
• Based on end-user, the academic and research laboratories segment held the largest revenue share in 2022. The widespread use of different SEA techniques in research settings has been influenced by a sizeable number of ongoing research projects at academic institutions that use SEA assays
• North America held the largest revenue share in 2022. This is mostly attributed to the occurrence of significant market participants and rising R&D spending and federal assistance
• Asia Pacific is expected to grow at the highest rate over the forecast period owing to factors such as the increasing prevalence of target diseases, growing aging population, and rising single cell technology adoption

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Application
  • 1.2.3. Workflow
  • 1.2.4. End-use
• 1.3. Information analysis
• 1.4. Market formulation & data visualization
• 1.5. Data validation & publishing
• 1.6. Information Procurement
  • 1.6.1. Primary Research
• 1.7. Information or Data Analysis
• 1.8. Market Formulation & Validation
• 1.9. Market Model
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Insights Landscape

Chapter 3. Single-cell Analysis Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook.
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Expanding application scope
    • 3.2.1.1.1. Disease diagnosis
    • 3.2.1.1.2. Drug discovery & development
    • 3.2.1.2. Lucrative growth of sequencing technology
    • 3.2.1.3. Technological innovations in single-cell analysis and cell isolation
    • 3.2.1.4. Rising incidence of cancer
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. High cost of instruments
    • 3.2.2.2. Higher penetration of conventional mode of gene & cell analysis
• 3.3. Single-cell Analysis Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's Five Forces
  • 3.3.2. PESTEL Analysis
  • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Single-cell Analysis Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Single-cell Analysis Market Product Movement Analysis
• 4.3. Global Single-cell Analysis Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
• 4.4. Consumables
  • 4.4.1. Consumables market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.2. Reagents
    • 4.4.2.1. Reagents market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.3. Assay Kits
    • 4.4.3.1. Assay kits market estimates and forecasts 2018 to 2030 (USD Million)
• 4.5. Instrument
  • 4.5.1. Instrument market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5.2. Microscope
    • 4.5.2.1. Microscope market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5.3. Hemocytometers
    • 4.5.3.1. Hemocytometers market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5.4. Flow cytometers
    • 4.5.4.1. Flow cytometers market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5.5. Next Generation Sequencing Systems
    • 4.5.5.1. Next generation sequencing systems market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5.6. PCR
    • 4.5.6.1. PCR market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5.7. High Content Screening Systems
    • 4.5.7.1. High content screening systems market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5.8. Cell Microarrays
    • 4.5.8.1. Cell microarrays market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5.9. Single Live Cell Imaging
    • 4.5.9.1. Single live cell imaging market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5.10. Automated Cell Counters
    • 4.5.10.1. Automated cell counters market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Single-cell Analysis Market: Application Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Single-cell Analysis Market Application Movement Analysis
• 5.3. Global Single-cell Analysis Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
• 5.4. Cancer
  • 5.4.1. Cancer market estimates and forecasts 2018 to 2030 (USD Million)
• 5.5. Immunology
  • 5.5.1. Immunology market estimates and forecasts 2018 to 2030 (USD Million)
• 5.6. Neurology
  • 5.6.1. Neurology market estimates and forecasts 2018 to 2030 (USD Million)
• 5.7. Stem Cell
  • 5.7.1. Stem cell market estimates and forecasts 2018 to 2030 (USD Million)
• 5.8. Non-invasive Prenatal Diagnosis
  • 5.8.1. Non-invasive prenatal diagnosis market estimates and forecasts 2018 to 2030 (USD Million)
• 5.9. In-vitro Fertilisation
  • 5.9.1. In-vitro fertilisation market estimates and forecasts 2018 to 2030 (USD Million)
• 5.10. Heart Cells
  • 5.10.1. Heart cells market estimates and forecasts 2018 to 2030 (USD Million)
• 5.11. Skeletal and Muscle Cells
  • 5.11.1. Skeletal and muscle cells market estimates and forecasts 2018 to 2030 (USD Million)
• 5.12. Others
  • 5.12.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Single-cell Analysis Market: Workflow Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global Single-cell Analysis Market Workflow Movement Analysis
• 6.3. Global Single-cell Analysis Market Size & Trend Analysis, by Workflow, 2018 to 2030 (USD Million)
• 6.4. Single Cell Isolation & Library Preparation
  • 6.4.1. Single cell isolation & library preparation market estimates and forecasts 2018 to 2030 (USD Million)
• 6.5. Downstream Analysis
  • 6.5.1. Downstream analysis market estimates and forecasts 2018 to 2030 (USD Million)
• 6.6. Data Analysis
  • 6.6.1. Data analysis market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Single-cell Analysis Market: End-Use Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Global Single-cell Analysis Market End-Use Movement Analysis
• 7.3. Global Single-cell Analysis Market Size & Trend Analysis, by End-Use, 2018 to 2030 (USD Million)
• 7.4. Academic and Research Laboratories
  • 7.4.1. Academic and research laboratories market estimates and forecasts 2018 to 2030 (USD Million)
• 7.5. Biotechnology and Pharmaceutical Companies
  • 7.5.1. Biotechnology and pharmaceutical companies market estimates and forecasts 2018 to 2030 (USD Million)
• 7.6. Hospitals and Diagnostic Laboratories
  • 7.6.1. Hospitals and diagnostic laboratories market estimates and forecasts 2018 to 2030 (USD Million)
• 7.7. Others
  • 7.7.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Single-cell Analysis Market: Regional Estimates & Trend Analysis By Product, Application, Workflow & End-use.

• 8.1. Regional Market Dashboard
• 8.2. Regional Market Share Analysis, 2024 & 2030
• 8.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 8.4. North America
  • 8.4.1. North America market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.2. U.S.
    • 8.4.2.1. Key country dynamics
    • 8.4.2.2. Regulatory framework
    • 8.4.2.3. Competitive scenario
    • 8.4.2.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.3. Canada
    • 8.4.3.1. Key country dynamics
    • 8.4.3.2. Regulatory framework
    • 8.4.3.3. Competitive scenario
    • 8.4.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
• 8.5. Europe
  • 8.5.1. Europe market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.2. UK
    • 8.5.2.1. Key country dynamics
    • 8.5.2.2. Regulatory framework
    • 8.5.2.3. Competitive scenario
    • 8.5.2.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.3. Germany
    • 8.5.3.1. Key country dynamics
    • 8.5.3.2. Regulatory framework
    • 8.5.3.3. Competitive scenario
    • 8.5.3.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.4. France
    • 8.5.4.1. Key country dynamics
    • 8.5.4.2. Regulatory framework
    • 8.5.4.3. Competitive scenario
    • 8.5.4.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.5. Italy
    • 8.5.5.1. Key country dynamics
    • 8.5.5.2. Regulatory framework
    • 8.5.5.3. Competitive scenario
    • 8.5.5.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.6. Spain
    • 8.5.6.1. Key country dynamics
    • 8.5.6.2. Regulatory framework
    • 8.5.6.3. Competitive scenario
    • 8.5.6.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.7. Norway
    • 8.5.7.1. Key country dynamics
    • 8.5.7.2. Regulatory framework
    • 8.5.7.3. Competitive scenario
    • 8.5.7.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.8. Sweden
    • 8.5.8.1. Key country dynamics
    • 8.5.8.2. Regulatory framework
    • 8.5.8.3. Competitive scenario
    • 8.5.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.9. Denmark
    • 8.5.9.1. Key country dynamics
    • 8.5.9.2. Regulatory framework
    • 8.5.9.3. Competitive scenario
    • 8.5.9.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 8.6. Asia Pacific
  • 8.6.1. Asia Pacific market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.2. Japan
    • 8.6.2.1. Key country dynamics
    • 8.6.2.2. Regulatory framework
    • 8.6.2.3. Competitive scenario
    • 8.6.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.3. China
    • 8.6.3.1. Key country dynamics
    • 8.6.3.2. Regulatory framework
    • 8.6.3.3. Competitive scenario
    • 8.6.3.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.4. India
    • 8.6.4.1. Key country dynamics
    • 8.6.4.2. Regulatory framework
    • 8.6.4.3. Competitive scenario
    • 8.6.4.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.5. Australia
    • 8.6.5.1. Key country dynamics
    • 8.6.5.2. Regulatory framework
    • 8.6.5.3. Competitive scenario
    • 8.6.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.6. South Korea
    • 8.6.6.1. Key country dynamics
    • 8.6.6.2. Regulatory framework
    • 8.6.6.3. Competitive scenario
    • 8.6.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.7. Thailand
    • 8.6.7.1. Key country dynamics
    • 8.6.7.2. Regulatory framework
    • 8.6.7.3. Competitive scenario
    • 8.6.7.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 8.7. Latin America
  • 8.7.1. Latin America market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.2. Brazil
    • 8.7.2.1. Key country dynamics
    • 8.7.2.2. Regulatory framework
    • 8.7.2.3. Competitive scenario
    • 8.7.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.3. Mexico
    • 8.7.3.1. Key country dynamics
    • 8.7.3.2. Regulatory framework
    • 8.7.3.3. Competitive scenario
    • 8.7.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.4. Argentina
    • 8.7.4.1. Key country dynamics
    • 8.7.4.2. Regulatory framework
    • 8.7.4.3. Competitive scenario
    • 8.7.4.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 8.8. MEA
  • 8.8.1. Middle East & Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.8.2. South Africa
    • 8.8.2.1. Key country dynamics
    • 8.8.2.2. Regulatory framework
    • 8.8.2.3. Competitive scenario
    • 8.8.2.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.8.3. Saudi Arabia
    • 8.8.3.1. Key country dynamics
    • 8.8.3.2. Regulatory framework
    • 8.8.3.3. Competitive scenario
    • 8.8.3.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.8.4. UAE
    • 8.8.4.1. Key country dynamics
    • 8.8.4.2. Regulatory framework
    • 8.8.4.3. Competitive scenario
    • 8.8.4.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.8.5. Kuwait
    • 8.8.5.1. Key country dynamics
    • 8.8.5.2. Regulatory framework
    • 8.8.5.3. Competitive scenario
    • 8.8.5.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Financial Performance
• 9.2. Participant Categorization
• 9.3. Company Market Position Analysis, 2024
• 9.4. Company Profiles/Listing
  • 9.4.1. Thermo Fisher Scientific, Inc
    • 9.4.1.1. Company overview
    • 9.4.1.2. Financial performance
    • 9.4.1.3. Product benchmarking
    • 9.4.1.4. Strategic initiatives
  • 9.4.2. QIAGEN NV
    • 9.4.2.1. Company overview
    • 9.4.2.2. Financial performance
    • 9.4.2.3. Product benchmarking
    • 9.4.2.4. Strategic initiatives
  • 9.4.3. Bio-Rad Laboratories, Inc.
    • 9.4.3.1. Company overview
    • 9.4.3.2. Financial performance
    • 9.4.3.3. Product benchmarking
    • 9.4.3.4. Strategic initiatives
  • 9.4.4. Illumina, Inc.
    • 9.4.4.1. Company overview
    • 9.4.4.2. Financial performance
    • 9.4.4.3. Product benchmarking
    • 9.4.4.4. Strategic initiatives
  • 9.4.5. Merck KGaA
    • 9.4.5.1. Company overview
    • 9.4.5.2. Financial performance
    • 9.4.5.3. Product benchmarking
    • 9.4.5.4. Strategic initiatives
  • 9.4.6. Becton, Dickinson & Company (BD)
    • 9.4.6.1. Company overview
    • 9.4.6.2. Financial performance
    • 9.4.6.3. Product benchmarking
    • 9.4.6.4. Strategic initiatives
  • 9.4.7. Fluidigm Corporation (Standard BioTools Inc.)
    • 9.4.7.1. Company overview
    • 9.4.7.2. Financial performance
    • 9.4.7.3. Product benchmarking
    • 9.4.7.4. Strategic initiatives
  • 9.4.8. 10x Genomics, Inc.
    • 9.4.8.1. Company overview
    • 9.4.8.2. Financial performance
    • 9.4.8.3. Product benchmarking
    • 9.4.8.4. Strategic initiatives
  • 9.4.9. BGI
    • 9.4.9.1. Company overview
    • 9.4.9.2. Financial performance
    • 9.4.9.3. Product benchmarking
    • 9.4.9.4. Strategic initiatives
  • 9.4.10. Novogene Co, Ltd.
    • 9.4.10.1. Company overview
    • 9.4.10.2. Financial performance
    • 9.4.10.3. Product benchmarking
    • 9.4.10.4. Strategic initiatives